FGF/FGFR signaling pathway involved resistance in various cancer types

被引：84
|
作者：
Zhou, Yangyang [1 ,2 ]
Wu, Chengyu [1 ,2 ]
Lu, Guangrong [2 ,3 ]
Hu, Zijing [4 ]
Chen, Qiuxiang [5 ]
Du, Xiaojing [6 ]
机构：
[1] Wenzhou Med Univ, Affiliated Hosp 2, Dept Rheumatol & Immunol, Wenzhou 325000, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Zhejiang, Peoples R China
[3] Wenzhou Med, Affiliated Hosp 2, Dept Gastroenterol, Wenzhou 325000, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Coll Pharmaceut Sci, Wenzhou 325000, Zhejiang, Peoples R China
[5] Wenzhou Med Univ, Affiliated Hosp 1, Dept Ultrason Imaging, South Baixiang, Wenzhou 325035, Zhejiang, Peoples R China
[6] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, South Baixiang, Wenzhou 325035, Zhejiang, Peoples R China
来源：
JOURNAL OF CANCER | 2020年 / 11卷 / 08期
关键词：
FGF/FGFR; resistance; oncotherapy; FGF/FGFR inhibitors; FIBROBLAST-GROWTH-FACTOR; CELL LUNG-CANCER; GASTROINTESTINAL STROMAL TUMOR; ACQUIRED-RESISTANCE; DRUG-RESISTANCE; INHIBITOR RESISTANCE; GATEKEEPER MUTATION; ESCAPE MECHANISM; KINASE; ACTIVATION;
D O I：
10.7150/jca.40531
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Resistance becomes major clinical issue in cancer treatment, which strongly limits patients to benefit from oncotherapy. Growing evidences have been indicative of the critical role of fibroblast growth factor (FGF)/receptor (FGFR) signaling played in resistance to oncotherapy. In this review we dicussed the underlying mechanisms of FGF/FGFR signaling mediated resistance to chemotherapy, radiotherapy and target therapy in various cancers. Meanwhile, we summarized the reported mechanism of FGF/FGFR inhibitors resistance in cancers.
引用
收藏
页码：2000 / 2007
页数：8
相关论文
共 50 条
  • [1] FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
    Szymczyk, Jakub
    Sluzalska, Katarzyna Dominika
    Materla, Izabela
    Opalinski, Lukasz
    Otlewski, Jacek
    Zakrzewska, Malgorzata
    CANCERS, 2021, 13 (22)
  • [2] FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
    Gao, Lixia
    Wang, Xuli
    Tang, Yaoliang
    Huang, Shuang
    Hu, Chien-An Andy
    Teng, Yong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [3] FGF/FGFR signaling in health and disease
    Xie, Yangli
    Su, Nan
    Yang, Jing
    Tan, Qiaoyan
    Huang, Shuo
    Jin, Min
    Ni, Zhenhong
    Zhang, Bin
    Zhang, Dali
    Luo, Fengtao
    Chen, Hangang
    Sun, Xianding
    Feng, Jian Q.
    Qi, Huabing
    Chen, Lin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [4] Clinical advances and challenges in targeting FGF/FGFR signaling in lung cancer
    Peng, Mei
    Deng, Jun
    Li, Xiangping
    MOLECULAR CANCER, 2024, 23 (01)
  • [5] The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention
    Mahapatra, Subhasmita
    Jonniya, Nisha Amarnath
    Koirala, Suman
    Ursal, Kapil Dattatray
    Kar, Parimal
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (22) : 13509 - 13533
  • [6] Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions
    Repetto, Matteo
    Crimini, Edoardo
    Giugliano, Federica
    Morganti, Stefania
    Belli, Carmen
    Curigliano, Giuseppe
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (10) : 1233 - 1252
  • [7] FGF9 promotes cisplatin resistance in colorectal cancer via regulation of Wnt/β-catenin signaling pathway
    Zhang, Zhijin
    Zhang, Yuhao
    Qin, Xinju
    Wang, Yuexia
    Fu, Jun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (03) : 1711 - 1718
  • [8] Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC
    Terai, Hideki
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Nakayama, Sohei
    Hamamoto, Junko
    Arai, Daisuke
    Ishioka, Kota
    Ohgino, Keiko
    Ikemura, Shinnosuke
    Sato, Takashi
    Yoda, Satoshi
    Satomi, Ryosuke
    Naoki, Katsuhiko
    Betsuyaku, Tomoko
    MOLECULAR CANCER RESEARCH, 2013, 11 (07) : 759 - 767
  • [9] New Insights in the Interaction of FGF/FGFR and Steroid Receptor Signaling in Breast Cancer
    Perez Pinero, Cecilia
    Giulianelli, Sebastian
    Lamb, Caroline A.
    Lanari, Claudia
    ENDOCRINOLOGY, 2022, 163 (02)
  • [10] Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
    Sobhani, Navid
    Fassl, Anne
    Mondani, Giuseppina
    Generali, Daniele
    Otto, Tobias
    CELLS, 2021, 10 (02) : 1 - 14
12345